Beth Hecht - Chief Legal Officer and Corporate Secretary at Xeris Biopharma Holdings, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Legal Officer and Corporate Secretary
Issuer Symbol
XERS on Nasdaq
All Insider Reports
All Insider Reports

Beth Hecht - trading volume in the past year for Xeris Biopharma Holdings, Inc.

Holdings reported by Beth Hecht for Xeris Biopharma Holdings, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1,226,507 $8,659,139 $7.06 02 Mar 2026 Direct
Stock Option (Right to Buy) 162,162 30 Jan 2026 Direct Common Stock

Transactions reported by Beth Hecht for Xeris Biopharma Holdings, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.